Abstract Voltage-gated sodium (Na V ) channel gating is a complex phenomenon which involves a distinct contribution of four integral voltage-sensing domains (VSDI, VSDII, VSDIII and VSDIV). Utilizing accrued pharmacological and structural insights, we build on an established chimera approach to introduce animal toxin sensitivity in each VSD of an acceptor channel by transferring in portable S3b-S4 motifs from the four VSDs of a toxin-susceptible donor channel (Na V 1.2). By doing so, we observe that in Na V 1.8, a relatively unexplored channel subtype with distinctly slow gating kinetics, VSDI-III participate in channel opening whereas VSDIV can regulate opening as well as fast inactivation. These results illustrate the effectiveness of a pharmacological approach to investigate the mechanism underlying gating of a mammalian Na V channel complex. 
Introduction
Within every phylum of the animal kingdom, voltagegated Na + (Na V ) channels are nature's answer to the need for intra-organism communication and coordination, particularly when speed is a biological necessity (Hille, 2001) . Utilizing the Na + gradient across the cell membrane, these proteins generate electrical signals that telegraph messages throughout the organism (Ahern et al. 2016) . As such, Na V channels support a myriad of critical physiological processes such as sensory perception, heart and brain function and muscle movement (George, 2005; Cannon, 2006; Catterall, 2012; Waxman et al. 2014) . Structurally, eukaryotic Na V channels are large 24-pass transmembrane proteins composed of four homologous domains (DI, II, III and IV) which form a pseudo-fourfold symmetric channel encompassing a central Na + -selective pore (segments 5-6; S5-S6) surrounded by four voltage sensors (segments 1-4; S1-S4), one from each domain (VSDI-IV) (Hille, 2001; Bezanilla, 2008; Ahern et al. 2016; Clairfeuille et al. 2016; Shen et al. 2017; Yan et al. 2017) . Accruing data gleaned from a subset of the nine mammalian Na V channel subtypes (Na V 1.1-Na V 11.9) suggest that channel gate opening is driven by VSDI-III activation whereas the subsequent movement of VSDIV initiates fast and/or slow inactivation (Chen et al. 1996; Kontis & Goldin, 1997; Cha et al. 1999; Kuhn & Greeff, 1999; Sheets et al. 1999; Jurkat-Rott et al. 2000; Mitrovic et al. 2000; Chanda & Bezanilla, 2002; Bosmans et al. 2008; Capes et al. 2013; Silva & Goldstein, 2013; Osteen et al. 2017) . Under physiological conditions, channel opening is associated with membrane depolarization and action potential initiation whereas fast inactivation prevents channels from reopening for a short period of time, thereby allowing the unidirectional propagation of action potentials (Kandel et al. 2012) .
The vital physiological role of Na V channels makes them a prime target for toxins produced by venomous animals which use these short peptides as a potent hunting tool or predator deterrent . Researchers have greatly benefitted from toxins by taking advantage of their exquisite target specificity to elucidate structural and functional aspects of voltage-gated ion channels or to explore their contribution to cellular excitability (Dutertre & Lewis, 2010; Kalia et al. 2015) . In general, toxins can bind to the pore region to impede Na + flux or they can interact with one or more VSDs to (1) inhibit channel opening; (2) induce channel opening at more negative voltages; or (3) delay fast inactivation to produce a persistent current (Bosmans & Swartz, 2010) . Typically, gating-modifier toxins bind to a specific region within VSDs, the S3b-S4 loop, a helix-turn-helix (paddle) motif that flexes in response to changes in membrane potential and makes few contacts with the rest of the channel protein (Li-Smerin & Swartz, 2000; Jiang et al. 2003; Long et al. 2007; Chakrapani et al. 2008; Bosmans & Swartz, 2010; Xu et al. 2010; Payandeh et al. 2011; Martin-Eauclaire et al. 2015; Ahern et al. 2016; Shen et al. 2017; Yan et al. 2017) . Consequently, this loop can be transplanted into corresponding voltage-gated K + (K V ) channel regions without disrupting the voltage-sensing process (Alabi et al. 2007; Bosmans et al. 2008 Bosmans et al. , 2011 . Moreover, the resulting chimeric K V channels gain sensitivity to an array of Na V channel toxins, a powerful tool that can be used to discover novel ligands that target specific VSDs (Bende et al. 2014; Klint et al. 2015) .
Here, we extend this chimera approach by swapping S3b-S4 loops between Na V channel subtypes (Fig. 1A) and treating the S3b-S4 loop-toxin pair as a transferrable module to introduce toxin sensitivity. We employ this method to establish the role of individual VSDs in the gating process of Na V 1.8, a slow-inactivating Na V channel subtype involved in nociception (Waxman et al. 2014) .
Methods
Toxins and chemicals. ProTx-II from the tarantula Thrixopelma pruriens and ATX-II from the sea anemone Anemonia sulcata were acquired from Peptides International (Louisville, KY, USA) and Alomone Labs (Jerusalem, Israel), respectively. AaHII from the Androctonus australis hector scorpion and TsVII (or Ts1 or Tsγ) from the Tityus serrulatus scorpion were a gift from Marie-France Martin-Eauclaire and Pierre Bougis (University of Marseille, France). HaTx from the Grammostola rosea tarantula was a gift from Kenton Swartz (NIH/NINDS, USA). Purified toxins were kept at −20°C and aliquots were dissolved in appropriate solutions containing 0.1% (m V −1 ) BSA. Chemicals used were from Sigma-Aldrich (USA) unless otherwise noted. . Na V channel S3b-S4 motifs and Na V 1.8 current rundown A, partial sequence alignment of VSDI-IV within rNa V 1.2 and rNa V 1.8 (used in this work) organized per domain. Transplantable regions are indicated in colour against a grey background. B, example of ß50% Na V 1.8 current rundown at +15 mV at a depolarizing pulse frequency of 0.2 Hz from a holding potential of −90 mV (top trace; black is first recording, green is current remaining after 5 min). Bottom trace shows no current rundown upon replacing the Ag + electrodes with agar bridges (3 M NaCl). C, progression of Na V 1.8 current rundown over a 5 min timeframe without (green) and with (black) agar bridges. Arrows indicate time points at which example traces shown in B were recorded. Error bars represent SEM, with n = 3.
Two-electrode voltage-clamp recordings from Xenopus laevis oocytes. The cDNA sequence of rat (r)Na V 1.2a, rNa V 1.8, rβ1 (Origene, Rockville, MD, USA), rK V 2.1, Na V 1.x-K V 2.1 VSD chimeras and mutant Na V channels was confirmed by automated DNA sequencing and cRNA was synthesized using T7 or SP6 polymerase (mMessage mMachine kit, Life Technologies, USA) after linearizing the DNA with applicable restriction enzymes. Na V channels were expressed with β1 (1:5 molar ratio) in Xenopus laevis oocytes (toads obtained from Xenopus one, Dexter, MI, USA) and studied following 2-4 days incubation after cRNA injection (incubated at 17°C in 96 mM NaCl, 2 mM KCl, 5 mM Hepes, 1 mM MgCl 2 and 1.8 mM CaCl 2 , 50 μg ml −1 gentamycin, pH 7.6 with NaOH) using the two-electrode voltage-clamp recording technique (OC-725C, Warner Instruments, Hamden, CT, USA) with a 150 μl recording chamber. Data were filtered at 4 kHz and digitized at 20 kHz using pClamp 10 software (Molecular Devices, Sunnyvale, CA, USA). Microelectrode resistances were 0.5-1.5 M when filled with 3 M KCl. For Na V channel experiments, the external recording solution contained (in mM): 100 NaCl, 5 Hepes, 1 MgCl 2 and 1.8 CaCl 2 , pH 7.6 with NaOH. For Na V 1.x/K V 2.1 chimera channel experiments, the external recording solution was (in mM): 50 KCl, 50 NaCl, 5 Hepes, 1 MgCl 2 and 0.3 CaCl 2 , pH 7.6 with NaOH. All experiments were performed at ß20°C. Leak and background conductances, identified by blocking the channel with agitoxin-2 (gift from Kenton Swartz (NIH/NINDS, USA)), were subtracted for K V channel currents. The use of animals was in compliance with US NIH guidelines and was approved by the Johns Hopkins University Animal Care and Use Committee.
After addition of a toxin to the recording chamber, equilibration between channel and toxin was monitored using depolarizations at 5 s intervals. Voltageactivation curves were obtained by measuring steady-state currents and calculating conductance for Na V channels or tail currents for K V channels, and a single Boltzmann function was fitted to the data according to
−1 , in which I/I max is the normalized tail-current amplitude, z is the equivalent charge, V 1/2 is the half-activation voltage, F is Faraday's constant, R is the gas constant and T is temperature in kelvin. P values mentioned in the text result from a statistical analysis using the paired Student's t test, typically comparing control to toxin application. Data are presented as means ± SEM Off-line data analysis was performed using Clampfit 10 (Molecular Devices, Sunnyvale, CA, USA), Origin 8.0 (Originlab, Northampton, MA, USA) and Microsoft Excel (Microsoft, Redmond, WA, USA).
Results
Na V 1.8 as a candidate acceptor for Na V 1.2 S3b-S4 regions.
We focused on Na V 1.8 as the recipient of previously J Physiol 596.10 defined Na V 1.2 S3b-S4 loops because its gating properties are relatively unexplored compared to other channel subtypes; yet, macroscopic current kinetics are substantially slower than those from neuronal or muscle Na V channel isoforms (Na V 1.1-Na V 1.7) (Akopian et al. 1996; Zhang et al. 2017) . Moreover, Na V 1.8 is insensitive to most toxins available to us, thereby providing a suitable background for generating gain-of-function chimeras. Aside from low expression levels, Na V 1.8-mediated currents in oocytes suffer from an apparent rundown upon repeated electrical stimulation (Choi & Soderlund, 2004) . Since this phenomenon typically does not occur when Na V 1.8 currents are recorded from mammalian cells, we hypothesized that removing the Ag + electrodes from the recording chamber by using agar bridges would resolve this issue. Indeed, Na V 1.8 current reduction tends to stabilize at ß50% after 5 min of depolarizing the membrane potential to +15 mV at 0.2 Hz from a holding potential of −90 mV ( Fig. 1B and C) . In contrast, no rundown is observed with the same pulse protocol when using agar bridges, suggesting a possible partial channel block upon interaction of Ag + with one of the species-and subtype-specific cysteines in the S5-S6 pore-forming regions (i.e. Cys 814/832/1333 ). In subsequent Na V 1.8 experiments, we therefore used agar bridges when recording from wild-type (WT) and chimeric channels.
VSDI is involved in Na V 1.8 opening. To determine the role of VSDI in Na V 1.8 gating, we exploited high-affinity ProTx-II binding to Na V 1.2 VSDI (Bosmans et al. 2008) by replacing this S3b-S4 loop sequence in Na V 1.8 with that of Na V 1.2 (Fig. 1A) and measure changes in ProTx-II sensitivity. (Chimeras are symbolized as follows; 8:8888 or 8:2888 where the number before the colon indicates the channel subtype (i.e. Na V 1.8) and after the colon each number represents the VSD identity of origin (i.e. 8:2888;
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Gating characteristics of Na V 1.8 and Na V 1.2-Na V 1.8 S3b-S4 loop chimeras Shown are the G-V (G/G max ) and SSI (steady-state inactivation; I/I max ) relationships of WT Na V 1.8 (black) and the four S3b-S4 Na V 1.2-Na V 1.8 chimeras (VSDI-IV in magenta, red, blue and green, respectively). See Fig. 1 for sequence alignment. V 1/2 and slope values were obtained from a Boltzmann fit of the data. Error bars are SEM, with n = 4.
VSDI from Na V 1.2 and VSDI-IV from Na V 1.8 (Fig. 3) . Thus, this experiment illustrates the role of VSDI in Na V 1.8 opening.
VSDII is coupled to Na V 1.8 opening. In most Na V channel subtypes, VSDII is the prime target for a large number of animal toxins characterized thus far . At 100 nM, ProTx-II also interacts with the S3b-S4 loop in Na V 1.2 VSDII to stabilize the voltage sensor in the closed state (Bosmans et al. 2008; Xiao et al. 2014) . When transferring only this loop into the corresponding location in Na V 1.8 ( Figs 1A and 2 ), 100 nM ProTx-II impedes 8:8288 activation, thereby suggesting coupling between VSDII and channel opening (Fig. 4A) . In contrast to ProTx-II, the β-scorpion toxin TsVII is thought to stabilize VSDII of Na V 1.2, but not Na V 1.8, in an activated state, thus allowing the channel to open at more hyperpolarized voltages (Marcotte et al. 1997; Campos et al. 2007; Bosmans et al. 2008) . Applying 100 nM TsVII to the 8:8288 chimera (Fig. 4B ) indeed recapitulates the effects seen on Na V 1.2 (Bosmans et al. 2008; Gilchrist et al. 2013) , an observation that further supports the role of Na V 1.8 VSDII in channel opening. ProTx-II interacts with VSDI, II and IV (see superscript summary after 'ProTx-II') in Na V 1.2 to inhibit channel opening (see 2:2222 column). Top shows a current trace whereas bottom depicts a G-V relationship before (black) and after (red) application of 100 nM ProTx-II. A small inhibitory effect was observed on WT Na V 1.8 (8:8888 column). In contrast, 100 nM ProTx-II strongly inhibits opening of the 8:2888 chimera. Current traces shown were recorded at voltages near the foot of the G-V curve for each construct (holding potential was −90 mV with 5 s between depolarizing pulses). V 1/2 = −27 ± 1 mV (2:2222 black), −8 ± 1 mV (2:2222 red), 4 ± 1 mV (8:8888 black), 6 ± 1 mV (8:8888 red), −6 ± 1 mV (8:2888 black), 9 ± 1 mV (8:2888 red). Error bars represent SEM, with n = 3.
VSDIII plays a role in Na V 1.8 opening. To our knowledge, Na V channel VSDIII-specific toxins have yet to be identified. One hypothesis for the lack of such peptides may be that nature found it more impactful to target VSDI, II, or IV to alter Na V channel function. Alternatively, toxin access to the VSDIII S3b-S4 region may be hampered by local lipid environment constraints (Lee & MacKinnon, 2004; Swartz, 2008; Milescu et al. 2009; Mihailescu et al. 2014; Gupta et al. 2015) . To circumvent this resource gap, we employed TsVII which binds to VSDII, III and IV in Na V 1.2 to hyperpolarize channel activation-voltage threshold while inhibiting current at depolarized voltages (Bosmans et al. 2008) . After substituting the endogenous Current traces shown were recorded at voltages near the foot of the G-V curve (holding potential was −90 mV with 5 s between depolarizing pulses). V 1/2 = −4 ± 1 mV (8:8288 black), 0 ± 1 mV (8:8288 red). Error bars represent SEM, with n = 3. B, TsVII interacts with VSDII, III and IV in Na V 1.2 to influence channel opening (Bosmans et al. 2008; Gilchrist et al. 2013 ) but does not affect Na V 1.8 when 1 µM is applied (left panel). In contrast, 100 nM TsVII clearly influences the 8:8288 chimera (middle panel) by promoting channel opening at hyperpolarized voltages ('lo' at −20 mV) and inhibiting currents at depolarized voltages ('hi' at 20 mV). These effects are exemplified by current traces in the right panel (holding potential was −90 mV). V 1/2 = 5 ± 1 mV (8:8888 black), 6 ± 1 mV (8:8888 red), −1 ± 1 mV (8:8288 black), −7 ± 1 mV (8:8288 red). Error bars represent SEM, with n = 5. VSDIII S3b-S4 loop in Na V 1.8 with that of Na V 1.2 (Fig. 1A) , we measured changes in susceptibility to 1 μM TsVII. The 8:8828 chimera is functional and the G-V and SSI relationship resemble that of 8:8888 (Figs 2 and 5 ). Upon application of 1 μM TsVII, 8:8888 function is not altered; however, 8:8828 opening is affected similarly to Na V 1.2 and the 8:8288 chimera (Fig. 4B) . In contrast to the 8:8288 chimera, which is sensitive to 100 nM TsVII, the 8:8828 chimera requires 1 μM TsVII to trigger an effect, suggesting that Na V 1.2 VSDIII is less susceptible to toxin binding.
VSDIV regulates Na V 1.8 inactivation and opening.
Among the four Na V channel VSDs, VSDIV is unique because transferring its S3b-S4 loop into K V channels consistently slows channel kinetics when compared to constructs containing S3b-S4 motifs from VSDI-III (Bosmans et al. 2008 (Bosmans et al. , 2011 Bende et al. 2014) . This observation fits the view that VSDIV plays a distinct role in inactivating the channel after it has opened (Sheets et al. 1999; Chanda & Bezanilla, 2002; Capes et al. 2013; Ahern et al. 2016) . As a result, animal toxins that primarily target the VSDIV S3b-S4 region commonly impede fast inactivation . To delineate the role of VSDIV in Na V 1.8 gating, we substituted the endogenous S3b-S4 loop sequence in this VSD with that of Na V 1.2 (Fig. 1A) and measured changes in susceptibility to ATX-II and AaHII, a sea anemone and α-scorpion toxin that interact with Na V 1.2 VSDIV (Rogers et al. 1996; Bosmans et al. 2008) . The 8:8882 chimera is functional and the G-V TsVII interacts with Na V 1.2 VSDI-IV to alter channel opening (Bosmans et al. 2008; Gilchrist et al. 2013 ) but has no effect on Na V 1.8 when 1 µM is applied (left panel, taken from Error bars represent SEM, with n = 3; * P < 0.01, * * P < 0.001.
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and SSI relationship is similar to that of the WT channel (8:8888) (Figs 6A and B and 2). Upon application of 100 nM ATX-II or AaHII, 8:8888 is not affected; however, 8:8882 fast inactivation slows down substantially and a persistent current appears at the end of a 50 ms depolarizing test pulse. These effects are similar to those seen with Na V 1.2 when applying 100 nM ATX-II or AaHII (Fig. 6A and B) .
To further substantiate the critical role of VSDIV in Na V 1.8 fast inactivation, we employed HaTx (100 nM) which does not affect WT Na V 1.8 gating but primarily targets VSDI and VSDII in Na V 1.2 to inhibit channel . Top shows a current trace whereas bottom depicts a G-V relationship before (black) and after (red) application of 100 nM ATX-II. No effect was observed on WT Na V 1.8 (8:8888 column). In contrast, 100 nM ATX-II does inhibit fast inactivation of the 8:8882 chimera. V 1/2 = −16 ± 1 mV (2:2222 black), −21 ± 1 mV (2:2222 red), 4 ± 1 mV (8:8888 black), 4 ± 1 mV (8:8888 red), 8 ± 1 mV (8:8882 black), 5 ± 1 mV (8:8882 red). Current traces shown were recorded using a 50 ms voltage step near the foot of the G-V curve for each construct (holding potential was −90 mV with 5 s between depolarizing pulses). Error bars represent SEM from n = 3-5 measurements. B, AaHII (100 nM) also interacts with VSDIV in Na V 1.2 (2:2222), but not Na V 1.8 (8:8888), in a manner similar to ATX-II. V 1/2 = −16 ± 1 mV (2:2222 black), −26 ± 1 mV (2:2222 red), 5 ± 1 mV (8:8888 black), 4 ± 1 mV (8:8888 red), 4 ± 1 mV (8:8882 black), 6 ± 1 mV (8:8882 red). Panel organization is identical to A with error bars representing SEM, with n = 4.
opening (Bosmans et al. 2008) . At this concentration, HaTx also binds to VSDIV but since channel opening typically occurs before inactivation (i.e. open-state inactivation), the principal effect on Na V 1.2 is to stabilize the closed state. If Na V 1.8 VSDIV is indeed coupled to fast inactivation, we expect HaTx to slow down this gating parameter upon transferring only the S3b-S4 region of Na V 1.2 VSDIV into Na V 1.8. Indeed, the 8:8882 chimera is sensitive to 100 nM HaTx and fast inactivation is strongly inhibited (Fig. 7) . Generally, VSDIV-targeting toxins as well as (disease) mutations in this region hamper fast inactivation without noticeably disrupting channel opening (Ji et al. 1996; Rogers et al. 1996; Campos et al. 2008; Gilchrist et al. 2014) . However, the inactivation gate may also close before the channel reaches a conducting state (i.e. closed-state inactivation). These phenomena inspired the formulation of a model in which VSDIV movement occurs in two consecutive stages: (1) partial VSDIV activation associated with channel opening after either VSDI-II or VSDIII activates, and (2) full activation of VSDIV after which the inactivation particle is free to prevent further conduction (Bean, 1981; Aldrich & Stevens, 1983; Cha et al. 1999; Horn et al. 2000; Chanda & Bezanilla, 2002; Chanda et al. 2004; Armstrong, 2006) . Similar to HaTx, prior work with chimeric K V 2.1 channels revealed that ProTx-II targets VSDI, VSDII and VSDIV of Na V 1.2 (Bosmans et al. 2008; Xiao et al. 2014 ). As a result, 100 nM ProTx-II strongly . Top shows a current trace whereas bottom depicts a G-V relationship before (black) and after (red) application of 100 nM HaTx. No effect was observed on WT Na V 1.8 (8:8888 column). In contrast, 100 nM HaTx inhibits fast inactivation of the 8:8882 chimera. Current traces shown were recorded using a 50 ms voltage step near the foot of the G--V curve for each construct (holding potential was −90 mV with 5 s between depolarizing pulses). V 1/2 = −11 ± 1 mV (2:2222 black), −9 ± 1 mV (2:2222 red), 6 ± 1 mV (8:8888 black), 7 ± 1 mV (8:8888 red), 8 ± 1 mV (8:8882 black), 10 ± 1 mV (8:8882 red). Error bars represent SEM from n = 4 measurements.
inhibits Na V 1.2 opening whereas WT Na V 1.8 is much less affected (Fig. 8A) . (Correspondingly, 100 nM ProTx-II does not inhibit the four S3b-S4 Na V 1.8-K V 2.1 chimeras (Fig. 8B) .) When applying ProTx-II to the 8:8882 chimera, we observe that the toxin binds to the channel to impede Na + influx over a wide voltage range (Fig. 8) . This result suggests that ProTx-II may affect the first, partial VSDIV movement to decrease channel conductance whereas HaTx, AaHII and ATX-II prevent full VSDIV activation resulting in fast inactivation inhibition.
Discussion
Na V channel gating is a multifaceted process in which VSDI-III and partial VSDIV activation is thought to contribute to channel opening whereas a subsequent VSDIV movement initiates inactivation (Armstrong, 2006; Ahern et al. 2016) , resulting in a complex biophysical landscape. Here, we expand a previously established chimera approach to anatomize the role of individual VSDs in Na V channel gating (Alabi et al. 2007; Bosmans et al. 2008; Milescu et al. 2009; Bende et al. 2014; Klint et al. 2015; Osteen et al. 2016) . Our pharmacological . Top shows a current trace whereas bottom depicts a G-V relationship before (black) and after (red) application of 100 nM ProTx-II. A minor inhibitory effect was observed on WT Na V 1.8 (8:8888 column). In contrast, 100 nM ProTx-II strongly inhibits opening of the 8:8882 chimera. Current traces shown were recorded at voltages near the foot of the G--V curve for each construct (holding potential was −90 mV with 5 s between depolarizing pulses). Error bars represent SEM, with n = 3. B, shown is a representative example of the effect of 100 nM ProTx-II on the four S3b-S4 Na V 1.8-K V 2.1 chimeras (VSDI-IV in magenta, red, blue and green, respectively). No significant inhibitory effect was observed.
method comprises a binary module consisting of an animal toxin and its S3b-S4 loop target that can be transferred between Na V channel subtypes (Fig. 1) to activate or inhibit particular VSDs that may be coupled to channel opening or inactivation. A key asset of this approach is that swapping an S3b-S4 helix-turn-helix loop has little impact on expression or function of the chimeric channel because structural constraints are minimal (Bosmans et al. 2008; Shen et al. 2017; Yan et al. 2017) . Moreover, animal toxins that target this region are highly specific and commonly bind with low nanomolar affinities . We used this approach to investigate the role of the four VSDs in the gating of Na V 1.8, a relatively understudied Na V channel subtype involved in nociception, with slow kinetics and low expression levels in oocytes. By using agar bridges to record rat Na V 1.8-mediated currents from oocytes, we avoided the apparent rundown as a response to repeated electrical stimulation (Fig. 1) . Upon transplanting previously defined S3b-S4 motifs from Na V 1.2 into Na V 1.8 (Bosmans et al. 2008 (Bosmans et al. , 2011 , we were able to introduce sensitivity to a range of toxins from spider, scorpion and sea anemone venom and demonstrate that VSDI, II and III participate in channel opening (Figs 2-7) . In contrast, toxin-mediated slowing of fast inactivation and ProTx-II-mediated inhibition of activation of the 8:8882 chimera suggest that VSDIV can mediate fast inactivation as well as opening of the channel, possibly because VSDIV movement occurs in two consecutive stages (Armstrong, 2006) . Altogether, our results illustrate that transferring the S3b-S4 loop-toxin module to introduce toxin sensitivity can help elucidate the role of individual VSDs in ion channel gating, studies that have typically been conducted using a combination of electrophysiology and sophisticated fluorescence measurements (Chanda & Bezanilla, 2002; Pless et al. 2014; Varga et al. 2015) . Propelled by emerging ion channel structural insights and the ongoing search for new VSD-targeting toxins, there is reason to think that this chimera method can be refined further (e.g. VSDI-or VSDIII-specific toxins) and that it could be used to probe the gating mechanisms of other voltage-gated ion channel families that share similar features (Payandeh et al. 2011; Wu et al. 2015 Wu et al. , 2016 Salari et al. 2016; Shen et al. 2017) .
